Abstract
Pathological calcification is common among for instance dialysis patients, and this causes an increase in mortality risk. An elevated serum phosphate concentration among those patients strongly correlates to this increase. In this work investigations of the conditions, composition, crystallinity and morphology of in vitro calcification are performed and related to results from in vivo studies. The study was performed under conditions mimicking physiological ones, i.e. a pH around 7.40, a temperature of 37°C, an ionic strength of 150 mM and ion concentrations close to those in human serum including the effects of elevated phosphate concentrations. The course of precipitation involves an initial precipitate that subsequently re-dissolves to give another precipitate, in accordance with the well-known Ostwald ripening theory. The final bulk precipitate consists of a macroscopically amorphous carbonated apatite. The amorphous apatite is formed from assemblies of spherical particles in the μm range, in turn composed of nano-crystalline needles of about 10 × 100 nm. Even the initially formed precipitate, as well as a small amount of precipitate that occurs on the liquid surface, consist of a carbonated calcium phosphate. The in vitro observed carbonated apatite bears strong resemblance to in vivo cardiovascular calcification known from literature.
Similar content being viewed by others
References
Hujairi NMA, Afzali B, Goldsmith DJA. Cardiac calcification in renal patients: what we do and don’t know. Am J Kidney Dis. 2004;43:234–43. doi:10.1053/j.ajkd.2003.10.014.
Blancher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938–42. doi:10.1161/hy1001.096358.
Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469–76. doi:10.1016/S0272-6386(00)70200-9.
Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–17. doi:10.1053/ajkd.1998.v31.pm9531176.
Dorozhkin SV, Dorozhkina EI, Epple M. Precipitation of carbonateapatite from a revised simulated body fluid in the presence of glucose. J Appl Biomat Biomech. 2003;1:200–7.
Peters F, Epple M. Simulating arterial wall calcification in vitro: biomimetic crystallization of calcium phosphates under controlled conditions. Z Kardiol. 2001;90:81–5. doi:10.1007/s003920170047.
Boulet M, Marier JR. Precipitation of calcium phosphates from solutions at near physiological concentrations. Arch Biochem Biophys. 1961;93:157–65. doi:10.1016/0003-9861(61)90329-0.
Boskey AL, Posner AS. Formation of hydroxyapatite at low supersaturation. J Phys Chem. 1976;80:40–5. doi:10.1021/j100542a009.
Olsson L-F, Sandin K, Odselius R, Kloo L. In vitro formation of nanocrystalline carbonate apatite---a structural and morphological analogue of atherosclerotic plaques. Eur J Inorg Chem.2007;26:4123–7.doi:10.1002/ejic.200700654.
Sandin K, Kloo L, Odselius R, Olsson L-F. The observation of nano-crystalline calcium phosphate precipitate in a simple supersaturated inorganic blood serum model - composition and morphology. J Appl Biomat Biomech. 2009, in press.
C. Lentner (Ed). Geigy scientific tables 3. Ciba-Geigy: Basle; 1984.
Clase CM, Norman GL, Beecroft ML, Churchill DN. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant. 2000;15:1841–6. doi:10.1093/ndt/15.11.1841.
Fowler BO. Infrared studies of apatites. I. Vibrational assignments for calcium, strontium, and barium hydroxyapatites utilizing isotopic substitution. Inorg Chem. 1974;13:194–207. doi:10.1021/ic50131a039.
Nelson DGA, Williamson BE. Low-temperature laser Raman spectroscopy of synthetic carbonated apatites and dental enamel. Aust J Chem. 1982;35:715–27.
Fowler BO, Markovic M, Brown WE. Octacalcium phosphate. 3. Infrared and Raman vibrational spectra. Chem Mater. 1993;5:1417–23. doi:10.1021/cm00034a009.
Nelson DGA, Featherstone JDB. Preparation, analysis and characterization of carbonated-apatites. Calcif Tissue Int. 1982;34:69–81.
Pritzko W, Rentsch H. Structure refinement with X-ray powder diffraction data for synthetic calcium hydroxyapatite by Rietveld method. Cryst Res Technol. 1985;20:957–60. doi:10.1002/crat.2170200719.
Rössler S, Sewing A, Stölzer M, Born R, Scharnweber D, Dard M, et al. Electrochemically assisted deposition of thin calcium phosphate coatings at near-physiological pH and temperature. J Biomed Mater Res. 2003;64A:655–63. doi:10.1002/jbm.a.10330.
JCPDS (The Joint Committee on Powder Diffraction Standards) 2601 Park Lane, Swarthmore, PA; 1974.
Nancollas GH. The involvement of calcium phosphates in biological mineralization and demineralization processes. Pure Appl Chem. 1992;64:1673–8. doi:10.1351/pac199264111673.
Ostwald W. Studien über die Bildung und Umwandlung fester Körper. Z Phys Chem. 1897;22:289–330.
Wang HP, Feng XJ, Gou BD, Zhang TL, Xu SJ, Wang K. Effects of LDL, cholesterol, and their oxidized forms on the precipitation kinetics of calcium phosphates. Clin Chem. 2003;49:2027–36. doi:10.1373/clinchem.2003.024513.
Alberius Henning P, Moustiakimov M, Lidin S. Incommensurately modulated cadmium apatites. J Solid State Chem. 2000;150:154–8. doi:10.1006/jssc.1999.8571.
Becker A, Epple M, Muller KM, Schmitz I. A comparative study of clinically well-characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods. J Inorg Biochem. 2004;98:2032–8. doi:10.1016/j.jinorgbio.2004.09.006.
Tomazic BB. Physiochemical principles of cardiovascular calcification. Z Kardiol. 2001;90(Suppl 3):68–80. doi:10.1007/s003920170046.
Bigi A, Compostella L, Fichera AM, Foresti E, Gazzano M, Ripamonti A, et al. Structural and chemical characterization of inorganic deposits in calcified human mitral valve. J Inorg Biochem. 1988;34:75–82. doi:10.1016/0162-0134(88)85019-0.
Pawlikowski M, Pfitzner R, Wachowiak J. Mineralization (calcification) of coronary arteries. Mater Med Pol. 1994;26:3–8.
Kim H-M, Himeno T, Kokubo T, Nakamura T. Process and kinetics of bonelike apatite formation on sintered hydroxyapatite in a simulated body fluid. Biomaterials. 2005;26:4366–73. doi:10.1016/j.biomaterials.2004.11.022.
Robinson RA. An electron-microscopic study of the crystallite inorganic component of bone and its relationship to the organic matrix. J Bone Jt Surg. 1952;34A:389–436.
Holt C, van Kemenade MJJM, Harries JE, Nelson LS, Bailey RT, Hukins DWL, et al. Preparation of amorphous calcium-magnesium phosphates at pH 7 and characterization by x-ray absorption and Fourier transform infrared spectroscopy. J Cryst Growth. 1988;92:239–52. doi:10.1016/0022-0248(88)90455-1.
Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg’s sclerosis. Circulation. 1999;100:2168.
Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2001;61:638–47. doi:10.1046/j.1523-1755.2002.00170.x.
Stability Constants Database; IUPAC, Academic software, 2001.
Acknowledgements
Hans Hallstadius, former employee at Gambro′s Development Department, is acknowledged for constructing the particle sensor and Andreas Fischer at the Department of Chemistry, Royal Institute of Technology, Stockholm, Sweden, for performing the TGA and X-ray diffraction investigations. This project was supported by a grant from the Swedish Research Council (VR 621-2001-3653).
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Concentrations were calculated by an in-house program system utilizing known equilibrium constants [33] for the conditions used. These data include complex formation, acid-base equilibrium, and solubility. When necessary, the values were corrected to apply to an ionic strength of 150 mM. The formation of complexes between calcium, phosphate and bicarbonate ions were taken into consideration. H2PO4 − (20%) and HPO4 2− (80%) are the dominating forms of orthophosphoric acid at pH 7.4. The other components, H3PO4 and PO4 3− were neglected. In the carbonate system, HCO3 − dominates (~95%); the other components are dissolved carbon dioxide (“carbonic acid”) CO2(aq) and the carbonate ion, CO3 2−. Since the concentration of the latter is <0.2 mM, the formation of the complex CaCO3(aq) was neglected. The acid constant pKa2 = 6.7 for the acid-base pair H2PO4 −/HPO4 2−. For the hydrogen carbonate system, the values have been obtained by interpolating between ionic strength 0.1 and 0.2 mM resulting in pKa1 = 6.07 for CO2(aq)/HCO3 − and pKa2 = 9.75 for HCO3 −/CO3 2−. The dissociation constant of water employed was pKw = 13.4. Only the complexes CaHPO4(aq) and CaHCO3 + with complex formation constants, logK, 1.9 and 1.1, respectively, were included.
Rights and permissions
About this article
Cite this article
Sandin, K., Kloo, L., Nevsten, P. et al. Formation of carbonated apatite particles from a supersaturated inorganic blood serum model. J Mater Sci: Mater Med 20, 1677–1687 (2009). https://doi.org/10.1007/s10856-009-3735-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-009-3735-z